{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:58:42Z","timestamp":1792403922892,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006691","name":"Harvard Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.radonc.2018.12.007","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T05:23:36Z","timestamp":1546233816000},"page":"112-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy"],"prefix":"10.1016","volume":"131","author":[{"given":"Puyao C.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert J.","family":"Liebsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Niemierko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drosoula","family":"Giantsoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simmons","family":"Lessell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara C.","family":"Fullerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1550-9726","authenticated-orcid":false,"given":"Helen A.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2018.12.007_b0005","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0161-6420(85)33898-8","article-title":"Radiation optic neuropathy","volume":"92","author":"Kline","year":"1985","journal-title":"Ophthalmology"},{"key":"10.1016\/j.radonc.2018.12.007_b0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00041327-200409000-00014","article-title":"Friendly fire: neurogenic visual loss from radiation therapy","volume":"24","author":"Lessell","year":"2004","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.radonc.2018.12.007_b0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1442-9071.2004.00809.x","article-title":"Radiation-induced optic neuropathy: still no treatment","volume":"32","author":"Miller","year":"2004","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.radonc.2018.12.007_b0020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0161-6420(90)32582-4","article-title":"Delayed radiation injury to the retrobulbar optic nerves and chiasm","volume":"97","author":"Roden","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.radonc.2018.12.007_b0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF03343560","article-title":"Inefficiency of anticoagulant therapy in the regression of radiation-induced optic neuropathy in Cushing\u2019s disease","volume":"22","author":"Barbarosa","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.radonc.2018.12.007_b0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/WNO.0b013e3182607381","article-title":"Novel treatment for radiation optic neuropathy with intravenous bevacizumab","volume":"32","author":"Farooq","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.radonc.2018.12.007_b0035","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ijrobp.2010.11.075","article-title":"Antivascular endothelial growth factor bevacizumab for radiation optic neuropathy: secondary to plaque radiotherapy","volume":"82","author":"Finger","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.12.007_b0040","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0161-6420(90)32537-X","article-title":"Gadolinium-DTPA-enhanced magnetic resonance imaging in optic neuropathies","volume":"97","author":"Guy","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.radonc.2018.12.007_b0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/brain\/84.1.85","article-title":"Delayed radionecrosis of the brain following therapeutic x-radiation of the pituitary","volume":"120","author":"Crompton","year":"1961","journal-title":"Brain"},{"key":"10.1016\/j.radonc.2018.12.007_b0050","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1148\/120.1.167","article-title":"Visual complications following irradiation for pituitary adenomas and craniopharyngiomas","volume":"120","author":"Harris","year":"1976","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2018.12.007_b0055","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ijrobp.2004.12.009","article-title":"Does altered fractionation influence the risk of radiation-induced optic neuropathy?","volume":"62","author":"Bhandare","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.12.007_b0060","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijrobp.2013.06.2047","article-title":"Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery","volume":"87","author":"Leavitt","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.12.007_b0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3171\/jns.1998.88.1.0043","article-title":"Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery","volume":"88","author":"Leber","year":"1998","journal-title":"J Neurosurg"},{"key":"10.1016\/j.radonc.2018.12.007_b0070","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.1016\/j.ijrobp.2011.05.012","article-title":"Stereotactic fractionated radiotherapy in the treatment of juxtapapillary choroidal melanoma: the McGill University experience","volume":"81","author":"Al-Wassia","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.12.007_b0075","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijrobp.2005.07.298","article-title":"Outcomes of visual acuity in carbon ion radiotherapy: analysis of dose-volume histograms and prognostic factors","volume":"64","author":"Hasegawa","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.12.007_b0080","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0360-3016(94)90346-8","article-title":"Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors","volume":"30","author":"Parsons","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.12.007_b0085","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0360-3016(77)90046-3","article-title":"The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation","volume":"2","author":"Aristizabal","year":"1977","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.12.007_b0090","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ijrobp.2009.07.1753","article-title":"Radiation dose-volume effects of optic nerves and chiasm","volume":"76","author":"Mayo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.12.007_b0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0167-8140(94)90005-1","article-title":"Radiation-induced injury to the visual pathway","volume":"30","author":"Jiang","year":"1994","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.12.007_b0100","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0360-3016(93)90065-4","article-title":"Probably causes of recurrence in patients with chordoma and chondrosarcoma of the base of the skull and cervical spine","volume":"25","author":"Austin","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.12.007_b0105","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/1097-0142(19950201)75:3<749::AID-CNCR2820750302>3.0.CO;2-D","article-title":"Optimization of radiotherapy for patients with cranial chordoma: a review of dose-reponse ratios for proton techniques","volume":"75","author":"Tai","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2018.12.007_b0110","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ijrobp.2011.08.004","article-title":"Challenges in linear accelerator radiotherapy for chordomas and chondrosarcomas of the skull base: focus on complications","volume":"83","author":"Hauptman","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.12.007_b0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0031-1275636","article-title":"Feasibility of proton beam therapy for chordoma and chondrosarcoma of the skull","volume":"21","author":"Fuji","year":"2011","journal-title":"Skull Base"},{"key":"10.1016\/j.radonc.2018.12.007_b0120","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00417-016-3429-4","article-title":"Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma","volume":"254","author":"Seibel","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.radonc.2018.12.007_b0125","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/1097-0142(19941015)74:8<2261::AID-CNCR2820740809>3.0.CO;2-0","article-title":"Base of skull chordoma: A correlative study of histologic and clinical features of 62 cases","volume":"74","author":"O\u2019Connell","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2018.12.007_b0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF03038890","article-title":"Proton Therapy for tumors of the skull base","volume":"175","author":"Muzenrider","year":"1999","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2018.12.007_b0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0360-3016(02)02754-2","article-title":"Relative biolocial effectiveness (RBE) values for proton beam therapy","volume":"53","author":"Paganetti","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.12.007_b0140","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.ijrobp.2010.10.027","article-title":"Variations in linear energy transfer within clinical proton therapy fields and the potential for biological treatment planning","volume":"80","author":"Grassberger","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.12.007_b0145","doi-asserted-by":"crossref","first-page":"8399","DOI":"10.1088\/0031-9155\/60\/21\/8399","article-title":"A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data","volume":"60","author":"McNamara","year":"2015","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2018.12.007_b0150","doi-asserted-by":"crossref","first-page":"20160116","DOI":"10.1259\/bjr.20160116","article-title":"Why RBE must be variable and not a constant in proton therapy","volume":"89","author":"Jones","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2018.12.007_b0155","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ijrobp.2008.12.068","article-title":"Analysis of vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves","volume":"75","author":"Demizu","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.12.007_b0160","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1200\/JCO.2002.07.132","article-title":"Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control - final report of intergroup 0114","volume":"20","author":"Tepper","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.12.007_b0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1200\/JCO.2005.03.171","article-title":"Influence of sex on toxicity and treatment outcome in small-cell lung cancer","volume":"23","author":"Singh","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.12.007_b0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0360-3016(00)00648-9","article-title":"Factors predicting severe radiation pneumonitis in patients receiving deWnitive chemoradiation for lung cancer","volume":"48","author":"Robnett","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.12.007_b0175","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0360-3016(02)02966-8","article-title":"Curative radiotherapy for primary orbital lymphoma","volume":"54","author":"Bhatia","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.12.007_b0180","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijrobp.2005.04.019","article-title":"Cauda equina tolerance to high-dose fractionated irradiation","volume":"64","author":"Pieters","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018336284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018336284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T01:37:50Z","timestamp":1565228270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814018336284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":36,"alternative-id":["S0167814018336284"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2018.12.007","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2018.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}